Ed Cinca, Senior Vice President, Marketing & Patient Solutions, Novo Nordisk, said: We know that patients are looking for additional options for weight loss, and with [7.2 mg semaglutide] we are answering that call. Self-paying adults prescribed the 7.2 mg semaglutide are set to pay $399 per month, with commercially insured patients potentially paying a fraction of the price, at $25 per month, Novo said
Tirzepatide reduced energy intake versus placebo at week 3 (estimated treatment difference 524.6 kcal (95% confidence interval 648.1 to 401.0), P 4 kg)
The FDA has issued warning letters to GLP-1 telehealth providers for deceptive practices
Given the rapid evolution of the science around incretins and related agents, a companion volume to Super Agers synthesizing outcomes data, mechanisms, long-term safety, and their integration with nutrition and exercise would be timely
Pigmentation fades gradually over 48 weeks if dosing stops entirely, returning to baseline within 1216 weeks in most users
Wear for up to 8 hours